title: Targeting EGFR in Triple Negative Breast Cancer.
abstract: Our preliminary data show that erlotinib inhibits Triple-negative breast cancer (TNBC) in a xenograft model. However, inhibition of metastasis by erlotinib is accompanied by nonspecific effects because erlotinib can inhibit other kinases; thus, more direct targets that regulate TNBC metastasis need to be identified to improve its therapeutic efficacy.
authors.affiliation: 1. Breast Cancer Translational Research Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
authors.forename: Naoto T
authors.initials: NT
authors.lastname: Ueno
authors.forename: Dongwei
authors.initials: D
authors.lastname: Zhang